Date | Title | Description |
- | Gamida Cell Announces Investment and Option Agreement with M... | Jerusalem, Israel, August 19, 2014 — Gamida Cell, a world leader in stem cell expansion technologies... |
- | ReWalk Robotics announces Australian approval, distribution ... | ReWalk Robotics has announced a collaboration with Making Strides, of Queensland, Australia. Making ... |
- | OrSense Introduces Glasswing, its Next-Generation, Wireless,... | Cancun, Mexico, July 9, 2012 – OrSense Ltd., developer of monitors for non-invasive measurements of ... |
- | First Patient Successfully Transplanted with Cryopreserved (... | Jerusalem, Israel, January 8, 2015 — Gamida Cell, a leader in cell therapy technologies and products... |
- | D-Pharm announces expected date of interim report for the DP... | D-Pharm Ltd., (TASE: DPRM) announced today that the interim report for the DP-b99 MACSI study is exp... |
- | Gamida Cell’s StemEx® Achieves Primary Endpoint in Phase II/... | Jerusalem, Israel – Gamida Cell announced today that its flagship product, StemEx, reached its prima... |
- | ReWalk Announces First U.S. Private Insurance Coverage for P... | Marlborough, MA — January 22, 2015 — Exoskeleton leader ReWalk Robotics announced today the first re... |
- | IDRI and Medicago to present data at the World Vaccine Congr... | SEATTLE, WA, and QUEBEC CITY, QC, April 9, 2013 – IDRI (Infectious Disease Research Institute), a Se... |
- | This Version of the ReWalk Personal Exoskeleton Offers Users... | YOKNEAM ILIT, ISRAEL / MARLBOROUGH, MASSACHUSETTS, July 14, 2015 — ReWalk Robotics Ltd. (Nasdaq: RWL... |
- | D Pharm expands Chinese cooperation agreement. The agreement... | D-Pharm Ltd. (TASE: DPRM) has expanded its commercialization agreement with China’s Wanbang Biopharm... |
- | Governor Patrick Joins Israeli-Founded ARGO Medical Technolo... | - |
- | NanoPass Technologies to Supply MicronJet600™ Device to Immu... | NanoPass Technologies Ltd. (“NanoPass”), a pioneer in intradermal delivery solutions for immunothera... |
- | - | NEW YORK, Jan. 7, 2013 /PRNewswire via COMTEX/ — Bed Bath & Beyond–the go-to resource for home a... |
- | - | ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use
Revolutionary technology that allow... |
- | NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study... | - |
- | First Pediatric Sickle Cell Disease Patient Receives NiCord®... | erusalem, Israel, November 12, 2012 — Gamida Cell Ltd., a world leader in stem cell population expan... |
- | ARGO Medical Technologies Announces European Commercial Laun... | DUSSELDORF, Germany, Oct 11, 2012 (BUSINESS WIRE) — Exoskeleton technology leader, ARGO Medical Tech... |
- | The Gamida Cell-Teva Joint Venture Concludes Enrollment for ... | Jerusalem, Israel, February 13, 2012 — Gamida Cell announced today that the Gamida Cell-Teva Joint V... |
- | NanoPass Technologies Grants an Exclusive License to Circass... | NanoPass Technologies Ltd. (“NanoPass”), a pioneer in intradermal delivery solutions for vaccines, a... |
- | OrSense’s Non-Invasive Hemoglobin Measurement System for Pre... | NES ZIONA, Israel, Oct 20, 2011 — OrSense Ltd., developer of monitors for non-invasive measurements ... |
- | Gamida Cell Reports StemEx® Phase II/III Study Safety and Ef... | Jerusalem, Israel, — Gamida Cell announced today additional analyses for the Phase II/III, multi-cen... |
- | Gamida Cell plans to commence Phase III study of NiCord in 2... | Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan geneti... |
- | ReWalk Robotics Ltd. Files Registration Statement for Propos... | YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., July 10, 2014 — ReWalk Robotics Ltd. (“ReWalk”) today a... |
- | ReWalk Robotics Announces Reimbursement Coverage by Major Ge... | YOKNEAM ILIT, ISRAEL / BERLIN, GERMANY / MARLBOROUGH, MASSACHUSETTS, September 23, 2014–ReWalk Robot... |
- | OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accur... | OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, annou... |
- | OrSense Receives FDA Clearance for its Noninvasive Hemoglobi... | - |
- | New Era Starts as ReWalk Exoskeleton Technology is Available... | LONDON–Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provi... |
- | OrSense detects hemorrhage, anemia during pregnancy | Israel’s OrSense , a developer of monitors for non-invasive measurements of various blood parameters... |
- | NanoPass Technologies Grants a Commercial License to Janssen... | - |
- | ARGO Medical Technologies Unveils Advancement of its Exoskel... | BERLIN, Jan 29, 2013 (BUSINESS WIRE) — ARGO Medical Technologies has unveiled the newest generation ... |
- | President Obama Views Demonstration of ReWalk Exoskeleton Te... | ARGO Medical Technologies’ ReWalk exoskeleton was one of the cutting-edge Israeli inventions demonst... |
- | Spaulding Rehabilitation Hospital Launches Exoskeleton Rehab... | Boston, MA – December 5, 2014 – Spaulding Rehabilitation Hospital Boston, one of the leading rehabil... |
- | GI View Receives 510(K) FDA Clearance for the Aer-O-Scope™ C... | Ramat Gan, Israel, December 2, 2014, GI View, developer of advanced GI screening systems, announced ... |
- | Agreement Will Launch First Ever Exoskeleton Rehabilitation ... | - |
- | Gamida Cell Announces the Successful Transplantation of the ... | We are witnessing a paradigm shift in transplantation. The first patient was successfully transplant... |
- | OrSense Non Invasive Hemoglobin Monitor Received CFDA Approv... | - |
- | Gamida Cell’s NiCord® Receives FDA and EMA Orphan Drug Desig... |
Jerusalem, Israel, January 6, 2015 — Gamida Cell, a leader in cell therapy technologies and produc... |
- | - |
Gamida Cell , a leader in adult stem cell expansion technologies and products, announced today tha... |
- | NanoPass Secures Series B Investment to Accelerate Commercia... | NanoPass Technologies Ltd., a pioneer in the development and commercialization of painless intraderm... |